Last week I talked about how a couple of small gene tweaks, using CRISPR-CAS9 technology, has massively reduced levels of “bad” cholesterol and triglycerides in lab mice. If this technology could be extended to humans, it could potentially lower the incidence of coronary heart disease and enable many people to live longer and in better health. Coronary heart disease is one of the two biggest killers of people in developed countries. The other big killer is cancer. CRISPR-CAS9 is being applied on this front as well. Continue reading →